# Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

> **NCT04588168** · NA · RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Chemotherapy
- **DIAGNOSTIC_TEST:** Immediate Multiparametric MRI
- **PROCEDURE:** Cystectomy and Lymphadenectomy
- **DIAGNOSTIC_TEST:** conventional Multiparametric MRI
- **DIAGNOSTIC_TEST:** Baseline Multiparametric MRI

## Key facts

- **NCT ID:** NCT04588168
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04588168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04588168, "Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04588168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*